Share Article
Urenco develops capabilities in nuclear stewardship
16 May 2019 Global NewsTo strengthen and broaden our existing business and ensure its long term sustainability, Urenco is implementing its strategic goals, including in the area of nuclear stewardship.
Decommissioning is a key area of growth for the nuclear industry and we are continuing to investigate opportunities to expand our work in this field.
Our UK subsidiary, Urenco Nuclear Stewardship, is leading this work, alongside its expertise in managing and recycling nuclear materials.
This is complemented by the work of another subsidiary, Urenco ChemPlants, also located in the UK. It will operate our new Tails Management Facility (TMF), which will manage the by-product of our enrichment services – depleted uranium hexafluoride (UF6) or tails – by converting it to stable uranium oxide (U3O8) for long-term storage pending reuse or final disposal.
Urenco’s 2018 Sustainability Report will be published on 6 June.
The film was made in collaboration with ITN Productions and the Chemical Industries Association as part of a programme called Solutions for our Future.
Share Article
About Urenco
Urenco is an international supplier of uranium enrichment services, fuel cycle products and related solutions with sustainability at the core of our business. Operating in a pivotal area of the nuclear fuel supply chain for over 50 years, Urenco understands the importance of energy security and facilitates the reliable delivery of low carbon electricity generation for consumers around the world.
With its head office in London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Through our technology and the expertise of our people, the Urenco Group provides safe, cost effective and reliable services, operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is making a positive contribution to global climate change goals through our core business and we are committed to achieving net zero carbon emissions by 2040.
We are committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries